Drug Pricing Bill in Jeopardy as Moderates Vote Against It (1)

Sept. 15, 2021, 8:04 PMUpdated: Sept. 15, 2021, 8:59 PM

House leaders vowed to press ahead with their health-care agenda Wednesday, even though enough Democrats oppose a key drug-pricing proposal to sink its chances in the House.

Reps. Kurt Schrader (D-Ore.), Scott Peters (D-Calif.) and Kathleen Rice (D-N.Y.) joined Republicans in opposing a bill to allow the government to demand lower prices from drugmakers and cap price increases on some medicines at the rate of inflation. The measure failed to advance in the House Energy and Commerce Committee on a 29-29 tied vote.

“We have to lower out-of-pocket costs for patients and preserve the American system of private investment in ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.